Article Text

Download PDFPDF
Dual mycobacterial infection in the setting of leflunomide treatment for rheumatoid arthritis
  1. S Agrawal,
  2. A Sharma
  1. Department of Medicine, Himalayan Institute of Medical Sciences, Dehradun, Uttaranchal, India
  1. Correspondence to:
    S Agrawal
    Department of Medicine, Himalayan Institute of Medical Sciences, Dehradun, Uttaranchal, India;sumeet.drsumeetagrawal{at}gmail.com

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Certain drugs used in the treatment for rheumatoid arthritis increase the risk of tuberculosis. These include corticosteroids, methotrexate and anti-tumour necrosis factor (TNF) agents. More recently, a possibility that leflunomide is associated with increased risk of tuberculosis has been discussed.1 A 36-year-old woman presented to the Department of Medicine, Himalayas Institute of Medical Sciences, Dehradun, Uttaranchal, India, with active rheumatoid arthritis for 4 years. She had been treated unsuccessfully with methotrexate in the past. Investigation showed normocytic-normochromic anaemia with a normal total and differential leucocyte counts, and a normal platelet count: an erythrocyte sedimentation rate (ESR) (Westergren’s Method) of …

View Full Text

Footnotes

  • Competing interests: None declared.